High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia

Published:2008-10 Issue:1 Volume:143 Page:54-59
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Cazin Bruno,Divine Marine,Leprêtre Stéphane,Travade Philippe,Tournilhac Olivier,Delmer Alain,Jaubert Jérôme,Feugier Pierre,Dreyfus Brigitte,Mahé Béatrice,Grosbois Bernard,Maloisel Frédéric,Eghbali Houchingue,Dumontet Charles,Bénichou Jacques,Guibon Odile,Leleu Xavier,Leporrier Michel,Maloum Karim

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07309.x/fullpdf

Reference28 articles.

1. Application of the triangular test to phase II cancer clinical trials;Bellissant;Statistics in Medicine,1990

2. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia;Bellosillo;Blood,1999

3. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia;Boogaerts;Journal of Clinical Oncology,2001

4. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab-incidence and predictors;Borthakur;British Journal Haematology,2007

5. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy;Byrd;Journal of Clinical Oncology,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of residual disease by flow cytometry in chronic lymphocytic leukemia: state of play of technical practices and prospects;HEMATOLOGIE;2019

2. Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study;The Lancet Haematology;2018-02

3. Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders;Expert Opinion on Biological Therapy;2017-09-11

4. Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia;Leukemia & Lymphoma;2015-09-28

5. Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia;Leukemia Research;2014-08